619 related articles for article (PubMed ID: 15193467)
1. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
[TBL] [Abstract][Full Text] [Related]
2. What can we learn from design faults in the Women's Health Initiative randomized clinical trial?
Tan O; Harman SM; Naftolin F
Bull NYU Hosp Jt Dis; 2009; 67(2):226-9. PubMed ID: 19583558
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
4. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy in the WHI era.
Burger HG
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
[TBL] [Abstract][Full Text] [Related]
7. WHI and aftermath: looking beyond the figures.
Pines A
Maturitas; 2005 May; 51(1):48-50. PubMed ID: 15883109
[TBL] [Abstract][Full Text] [Related]
8. A comparative review of the risks and benefits of hormone replacement therapy regimens.
Warren MP
Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
[TBL] [Abstract][Full Text] [Related]
9. Indications for hormone therapy: the post-Women's Health Initiative era.
Reed SD; Newton KM; Lacroix AZ
Endocrinol Metab Clin North Am; 2004 Dec; 33(4):691-715. PubMed ID: 15501641
[TBL] [Abstract][Full Text] [Related]
10. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy: currently no evidence for cardiac protection.
Wenger NK
Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
[TBL] [Abstract][Full Text] [Related]
12. [What is the actual lesson from the WHI study upon its completion?].
Pines A
Harefuah; 2004 Oct; 143(10):722-3, 766. PubMed ID: 15521348
[TBL] [Abstract][Full Text] [Related]
13. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
Rigby AJ; Ma J; Stafford RS
Menopause; 2007; 14(5):853-8. PubMed ID: 17429334
[TBL] [Abstract][Full Text] [Related]
14. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
16. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
[TBL] [Abstract][Full Text] [Related]
17. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
Langer RD
Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
[TBL] [Abstract][Full Text] [Related]
18. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
19. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
20. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
